5
1
9781780644394
Antimicrobial Stewardship: Principles and Practice available in Hardcover, eBook
Antimicrobial Stewardship: Principles and Practice
by Eleftherios Mylonakis, Louis Rice, Kerry LaPlante, Cheston Cunha, Haley Morrill
Eleftherios Mylonakis
- ISBN-10:
- 1780644396
- ISBN-13:
- 9781780644394
- Pub. Date:
- 01/31/2017
- Publisher:
- CABI
Antimicrobial Stewardship: Principles and Practice
by Eleftherios Mylonakis, Louis Rice, Kerry LaPlante, Cheston Cunha, Haley Morrill
Eleftherios Mylonakis
$280.05
Current price is , Original price is $280.05. You
Buy New
$280.05
$280.05
280.05
In Stock
Overview
In an age where antimicrobial resistance among pathogens grows more prevalent, particularly in the hospital setting, antimicrobial stewardship is an evidence-based, proven measure in the battle against resistance and infection.This comprehensive, definitive reference work is written by an international team of acknowledged experts in the field. The authors explore the effective use of coordinated antimicrobial interventions to change prescribing practice and help slow the emergence of antimicrobial resistance, ensuring that antimicrobials remain an effective treatment for infection.Among the first of its kind, Antimicrobial Stewardship provides infectious disease physicians, administrators, laboratory, pharmacy, nursing, and medical staff practical guidance in setting up antimicrobial stewardship programs in their institutions with the aim of selecting the optimal antimicrobial drug regimen, dose, duration of therapy, and route of administration.
Product Details
ISBN-13: | 9781780644394 |
---|---|
Publisher: | CABI |
Publication date: | 01/31/2017 |
Pages: | 450 |
Product dimensions: | 7.50(w) x 9.62(h) x (d) |
About the Author
Eleftherios Mylonakis is a physician-scientist, and his work focuses on the study of microbial pathogenesis and drug discovery. His research has developed a novel alternative to studying bacterial and fungal infection and host responses: the use of invertebrate model hosts. These surrogate invertebrate hosts fill an important niche in fungal pathogenesis research. His investigations have identified novel virulence factors, cross kingdom pathogen-pathogen interactions, novel antifungal agents, and evolutionarily conserved traits that are involved in host virulence and immune responses during infection. Recently, Dr. Mylonakis implemented high-throughput whole-animal Caenorhabditis elegans assay to screen libraries of chemical compounds and identify those with antimicrobial activity. In vivo evaluation of libraries of chemical compounds could solve some of the main obstacles in current antifungal discovery, such as finding new classes of compounds and solving the bottleneck of toxicity/efficacy testing. This approach challenges the position that studies in fungal pathogenesis should focus on the analysis of the "host," the "pathogen," or the "antimicrobial compound." Dr. Mylonakis has published over 150 articles in the scientific literature, and peer-reviewed grants from the National Institutes of Health and private foundations have supported his studies. He is the founding Editor-in-Chief of the journal Virulence and serves on the editorial boards of many publications and as an ad hoc reviewer for over 40 journals.
Louis Rice is at Rhode Island Hospital.
Kerry LaPlante is a tenured Professor of Pharmacy at the University of Rhode Island, an Adjunct Professor of Medicine at Brown University, and the Founding Director of the Antimicrobial Stewardship Research Fellowship at the Providence Veterans Medical Center. Her work is dedicated to furthering antibiotic education and research across the full spectrum of healthcare science, from antibiotic development to clinical applications. An internationally recognized leader in the field of antibiotic research, Dr. LaPlante is an elected Fellow of the American College of Clinical Pharmacy, and has served on the editorial boards for the leading journals in pharmacy and pathogenic microbiology. She is frequently invited to lecture at national infectious diseases meetings and symposia, and is an author on over 60 peer-reviewed articles, and book chapters, which span topics from antimicrobial stewardship, antibiotic resistance, drug discovery and in vitro activity of combination antimicrobial agents.
Cheston Cunha is at Brown University.
Haley Morrill is at Veterans Affairs Medical Center.
Louis Rice is at Rhode Island Hospital.
Kerry LaPlante is a tenured Professor of Pharmacy at the University of Rhode Island, an Adjunct Professor of Medicine at Brown University, and the Founding Director of the Antimicrobial Stewardship Research Fellowship at the Providence Veterans Medical Center. Her work is dedicated to furthering antibiotic education and research across the full spectrum of healthcare science, from antibiotic development to clinical applications. An internationally recognized leader in the field of antibiotic research, Dr. LaPlante is an elected Fellow of the American College of Clinical Pharmacy, and has served on the editorial boards for the leading journals in pharmacy and pathogenic microbiology. She is frequently invited to lecture at national infectious diseases meetings and symposia, and is an author on over 60 peer-reviewed articles, and book chapters, which span topics from antimicrobial stewardship, antibiotic resistance, drug discovery and in vitro activity of combination antimicrobial agents.
Cheston Cunha is at Brown University.
Haley Morrill is at Veterans Affairs Medical Center.
Table of Contents
Part I: Overview of Antibiotic Stewardship1: Principles of Antimicrobial Stewardship2: Clinical Perspective of Antimicrobial Stewardship3: History of Antimicrobial Stewardship4: The Importance of Education in Antimicrobial StewardshipPart II: Antibiotic Resistance Principles in Antibiotic Stewardship5: Intrinsic and Acquired Mechanisms of Resistance6: Antimicrobial Resistance: Selection vs. Induction7: Colonization and its Importance for Emergence of Clinical Resistance8: Antibiotic Resistance: Associations and Implications for Antibiotic Usage Strategies to Control Multi-resistant BacteriaPart III: Microbiology Laboratory Role in Antibiotic Stewardship9: The Role of Active Surveillance in the Prevention of Healthcare-acquired Infections and Antibiotic Stewardship10: Role of Antibiogram in Antibiotic Stewardship11: Selective Reporting and Antimicrobial Stewardship12: Role of New Diagnostics to Enhance Antibiotic Stewardship EffortsPart IV: Infection Control Aspects of Antibiotic Stewardship13: Epidemiology of S Aureus and Enterococci in Children and an Overview of Antimicrobial Resistance14: Epidemiology of Multi-drug Resistant Gram-negative Organisms15: Pathogenesis and Epidemiology of Clostridium Difficile Infection: Implications for Antibiotic Stewardship16: Role of the Hospital Epidemiologist in Supporting Antimicrobial StewardshipPart V: Pharmacokinetic (PK) & Pharmacodynamic (PD) Aspects of Antibiotic Dosing in Antibiotic Stewardship17: Principles of Pharmacokinetic / Pharmacodynamic Optimization for Antibiotic Dosing18: Optimal use of Gram-negative Antibiotics in the Real World: Providing Effective Therapy While Minimizing Resistance19: Optimal Use of Fluoroquinolones20: Optimal Use of Beta-lactam Antibiotics21: Current Approach to Optimal Use and Dosing of Vancomycin in Adult Patients22: Principles of IV to PO SwitchPart VI: Pharmacy Department Role in Antibiotic Stewardship23: Role of Pharmacists in Antimicrobial Stewardship24: Formulary Management and Economic Considerations; Bridging the Gap between Quality Care and Cost25: Approaches in Benchmarking26: Development and Execution of Stewardship Interventions27: Technologic Support for Antimicrobial StewardshipPart VII: Measuring Outcomes in Antibiotic Stewardship Programs28: Role of Guidelines and Statistical Milestones for Antimicrobial Stewardship29: Economic Considerations of Antimicrobial Stewardship Programs30: Pharmacoeconomic Implications of Antimicrobial Adverse Events31: Antimicrobial Stewardship Programs in Areas of Increased Pathogen ResistancePart VIII: Antimicrobial Stewardship and Various Practice Sites32: Role of Antimicrobial Stewardship in Pediatrics33: Antimicrobial Stewardship in the Intensive Care Unit34: Role of Antimicrobial Stewardship in a Community Hospital35: Outpatient Parenteral Antimicrobial Therapy (OPAT)36: The Importance of Interdisciplinary Collaboration in Antimicrobial Stewardship: Immersion of Future Healthcare Professionals37: Antimicrobial Stewardship and the Importance of Working with the Government and Pharmaceutical Industry38: Hospitalist Perspective on the Role of Antimicrobial StewardshipFrom the B&N Reads Blog
Page 1 of